Recommendations for the Use of Pharmacological Smoking Cessation Strategies in Pregnant Women
Author:
- 1 January 2007
- journal article
- review article
- Published by Springer Nature in CNS Drugs
- Vol. 21 (12) , 983-993
Abstract
Maternal smoking during pregnancy causes significant fetal morbidity and is a public health problem, as 36% of women in the UK and 11% of those in the US smoke during pregnancy. Behavioural support...Keywords
This publication has 43 references indexed in Scilit:
- Prevalence of maternal smoking and environmental tobacco smoke exposure during pregnancy and impact on birth weight: retrospective study using Millennium CohortBMC Public Health, 2007
- Bupropion in pregnancy and the prevalence of congenital malformationsPharmacoepidemiology and Drug Safety, 2006
- Challenges and solutions for recruiting pregnant smokers into a nicotine replacement therapy trialNicotine & Tobacco Research, 2006
- U.K. general practitioners' beliefs, attitudes, and reported prescribing of nicotine replacement therapy in pregnancyNicotine & Tobacco Research, 2005
- COX 2 inhibitors, traditional NSAIDs, and the heartBMJ, 2005
- Accelerated Metabolism of Nicotine and Cotinine in Pregnant SmokersThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Drug???Induced Congenital DefectsDrug Safety, 2001
- Nicotine patches for pregnant smokers: a randomized controlled studyObstetrics & Gynecology, 2000
- The use of pharmacotherapies for smoking cessation during pregnancyTobacco Control, 2000
- Children and smoking: the family circleBritish Medical Bulletin, 1996